当前位置:首页 - 行情中心 - 共同药业(300966) - 财务分析 - 现金流量表

共同药业

(300966)

  

流通市值:16.87亿  总市值:25.36亿
流通股本:7666.66万   总股本:1.15亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金187,423,903.0787,260,458.57451,575,401.16353,642,112.41
  收到的税费返还27,173,040.1111,352,219.768,146,056.5760,748,351.75
  收到其他与经营活动有关的现金8,253,422.638,555,572.46116,630,481.9675,546,325.33
  经营活动现金流入小计222,850,365.81107,168,250.73636,351,939.69489,936,789.49
  购买商品、接受劳务支付的现金143,903,659.3392,244,522.07517,457,150.25278,704,020.32
  支付给职工以及为职工支付的现金44,200,351.1523,247,367.3367,227,772.4549,871,781.52
  支付的各项税费15,757,437.997,888,354.3720,895,272.3917,934,060.16
  支付其他与经营活动有关的现金24,781,812.1712,562,288.4951,360,192.2350,150,567.04
  经营活动现金流出小计228,643,260.64135,942,532.26656,940,387.32396,660,429.04
  经营活动产生的现金流量净额-5,792,894.83-28,774,281.53-20,588,447.6393,276,360.45
二、投资活动产生的现金流量:
  收回投资收到的现金0---
  取得投资收益收到的现金0--0
  处置固定资产、无形资产和其他长期资产收回的现金净额133,709133,309118,400103,904.42
  处置子公司及其他营业单位收到的现金净额0---
  收到的其他与投资活动有关的现金--17,157,465.1357.93
  投资活动现金流入小计133,709133,30917,275,865.13103,962.35
  购建固定资产、无形资产和其他长期资产支付的现金115,639,950.7782,259,738.98311,613,852.76328,954,297.32
  投资支付的现金0---
  质押贷款净增加额0---
  取得子公司及其他营业单位支付的现金0---
  支付其他与投资活动有关的现金0--0
  投资活动现金流出小计115,639,950.7782,259,738.98311,613,852.76328,954,297.32
  投资活动产生的现金流量净额-115,506,241.77-82,126,429.98-294,337,987.63-328,850,334.97
三、筹资活动产生的现金流量:
  吸收投资收到的现金0-24,500,00024,500,000
  其中:子公司吸收少数股东投资收到的现金0-24,500,00024,500,000
  取得借款收到的现金250,918,608.07123,931,436.69723,589,646.66586,168,158.75
  收到其他与筹资活动有关的现金29,110,776.559,934,277.7832,001,500-
  筹资活动现金流入小计280,029,384.62133,865,714.47780,091,146.66610,668,158.75
  偿还债务支付的现金148,390,00033,020,000434,195,867.85377,095,867.85
  分配股利、利润或偿付利息支付的现金9,576,063.122,901,455.8525,692,538.2913,018,014.43
  其中:子公司支付给少数股东的股利、利润0---
  支付其他与筹资活动有关的现金3,030,264.521,921,250.12798,650671,305.08
  筹资活动现金流出小计160,996,327.6437,842,705.97460,687,056.14390,785,187.36
  筹资活动产生的现金流量净额119,033,056.9896,023,008.5319,404,090.52219,882,971.39
四、汇率变动对现金及现金等价物的影响89,458.955,663.29-561,781.531,103,231.52
五、现金及现金等价物净增加额-2,176,620.72-14,822,039.723,915,873.73-14,587,771.61
  加:期初现金及现金等价物余额100,122,033.02100,122,033.0296,206,159.2996,206,159.29
  期末现金及现金等价物余额97,945,412.385,299,993.3100,122,033.0281,618,387.68
补充资料:
  净利润-14,654,445.7--31,656,138.87-
  资产减值准备5,172,986.61-17,547,611.61-
  固定资产和投资性房地产折旧52,265,209.14-42,618,192.09-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧52,265,209.14-42,618,192.09-
  无形资产摊销557,212.56-363,969.88-
  长期待摊费用摊销1,653,769.38-3,307,538.77-
  处置固定资产、无形资产和其他长期资产的损失1,568,177.45--113,563.03-
  固定资产报废损失1,215,637.53-1,481,684.71-
  公允价值变动损失-0.07--0.18-
  财务费用23,517,172.44-24,808,489.94-
  投资损失219,416.42-349,407.59-
  递延所得税-9,449,316.33--14,947,970.25-
  其中:递延所得税资产减少-9,612,189.63--14,669,186.77-
    递延所得税负债增加162,873.3--278,783.48-
  存货的减少-55,258,045.83--43,313,376.35-
  经营性应收项目的减少-44,878,873.65-8,557,292.44-
  经营性应付项目的增加31,978,578.94--29,828,982.38-
  其他271,275.62--25,205.96-
  现金的期末余额97,945,412.3-100,122,033.02-
  减:现金的期初余额100,122,033.02-96,206,159.29-
  现金及现金等价物的净增加额-2,176,620.72-3,915,873.73-
公告日期2025-08-292025-04-292025-04-242024-10-24
审计意见(境内)标准无保留意见
TOP↑